Search research articles
Contact Us
Filters
Showing results (1-10 of 118) with videos related to
Page
of 12
Sort By:
Current Cancer Drug Targets
|
June 17, 2015
Current Drug Targets for Thymic Neoplasms
Xiao-Ling Xu, Wei-Min Mao
Chronic Diseases and Translational Medicine
|
October 25, 2017
Esophageal ulcer induced by ibuprofen tablets
Xiao-Ling Xu, Hai-Hang Zhu, Jian Yin
Bioscience Reports
|
August 23, 2019
LINC00511 is associated with the malignant status and promotes cell proliferation and motility in cervical cancer
Chun-Ling Yu, Xiao-Ling Xu, Fang Yuan
International Journal of Nanomedicine
|
June 10, 2025
How Do Organelle-Targeting Nanotherapeutics Treat Inflammatory Diseases? A Comprehensive Review of the Literature
Si-Hui Wang, Xiao-Ling Xu, Wei Chen
Current Drug Targets
|
January 18, 2021
Endogenous Enzyme-responsive Nanoplatforms for Anti-tumor Therapy
Xue-Fang Lou, Yong-Zhong Du, Xiao-Ling Xu
Bioprocess and Biosystems Engineering
|
April 28, 2009
A novel biotransformation process of 4'-demethylepipodophyllotoxin to 4'-demethylepipodophyllic acid by Bacillus fusiformis CICC 20463, Part II: process optimization
Ya-Jie Tang, Xiao-Ling Xu, Jian-Jiang Zhong
Current Drug Targets
|
July 20, 2020
Progress in the Understanding of the Immune Microenvironment and Immunotherapy in Malignant Pleural Mesothelioma
Lei Cheng, Na Li, Xiao-Ling Xu, et al.
Cancer Medicine
|
June 24, 2016
RRM1 *151A>T, RRM1 -756T>C, and RRM1 -585T>Gis associated with increased susceptibility of lung cancer in Chinese patients
Xiao-Ling Xu, Ji Zheng, Wei-Min Mao, et al.
Medicine
|
June 11, 2015
Is There a Survival Benefit in Patients With Stage IIIA (N2) Non-small Cell Lung Cancer Receiving Neoadjuvant Chemotherapy and/or Radiotherapy Prior to Surgical Resection: A Systematic Review and Meta-analysis
Ya-Ping Xu, Bo Li, Xiao-Ling Xu, et al.
Expert Opinion on Drug Delivery
|
August 11, 2025
Recent advances in dissolving microneedle delivery systems for breast cancer therapy
Jingqi Sun, Yutong Zhao, Zicong Xu, et al.
Page
of 12
Search research articles
Search
Showing results (1-10 of 118) with videos related to
Sort By:
Page
of 12
Current Cancer Drug Targets
|
June 17, 2015
Current Drug Targets for Thymic Neoplasms
Xiao-Ling Xu, Wei-Min Mao
Chronic Diseases and Translational Medicine
|
October 25, 2017
Esophageal ulcer induced by ibuprofen tablets
Xiao-Ling Xu, Hai-Hang Zhu, Jian Yin
Bioscience Reports
|
August 23, 2019
LINC00511 is associated with the malignant status and promotes cell proliferation and motility in cervical cancer
Chun-Ling Yu, Xiao-Ling Xu, Fang Yuan
International Journal of Nanomedicine
|
June 10, 2025
How Do Organelle-Targeting Nanotherapeutics Treat Inflammatory Diseases? A Comprehensive Review of the Literature
Si-Hui Wang, Xiao-Ling Xu, Wei Chen
Current Drug Targets
|
January 18, 2021
Endogenous Enzyme-responsive Nanoplatforms for Anti-tumor Therapy
Xue-Fang Lou, Yong-Zhong Du, Xiao-Ling Xu
Bioprocess and Biosystems Engineering
|
April 28, 2009
A novel biotransformation process of 4'-demethylepipodophyllotoxin to 4'-demethylepipodophyllic acid by Bacillus fusiformis CICC 20463, Part II: process optimization
Ya-Jie Tang, Xiao-Ling Xu, Jian-Jiang Zhong
Current Drug Targets
|
July 20, 2020
Progress in the Understanding of the Immune Microenvironment and Immunotherapy in Malignant Pleural Mesothelioma
Lei Cheng, Na Li, Xiao-Ling Xu, et al.
Cancer Medicine
|
June 24, 2016
RRM1 *151A>T, RRM1 -756T>C, and RRM1 -585T>Gis associated with increased susceptibility of lung cancer in Chinese patients
Xiao-Ling Xu, Ji Zheng, Wei-Min Mao, et al.
Medicine
|
June 11, 2015
Is There a Survival Benefit in Patients With Stage IIIA (N2) Non-small Cell Lung Cancer Receiving Neoadjuvant Chemotherapy and/or Radiotherapy Prior to Surgical Resection: A Systematic Review and Meta-analysis
Ya-Ping Xu, Bo Li, Xiao-Ling Xu, et al.
Expert Opinion on Drug Delivery
|
August 11, 2025
Recent advances in dissolving microneedle delivery systems for breast cancer therapy
Jingqi Sun, Yutong Zhao, Zicong Xu, et al.
Page
of 12